Status:
COMPLETED
Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device
Lead Sponsor:
ChairsideSplint.com
Conditions:
Chronic Migraine, Headache
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Single blinding study comparing FDA cleared device for prevention of medically diagnosed migraine pain to placebo.
Detailed Description
In order to determine if nocturnal jaw clenching can be an influence on chronic migraine pain, the FDA cleared "NTI" (Nociceptive Trigeminal Inhibition) device with the Indications for Use of "for pro...
Eligibility Criteria
Inclusion
- Diagnosed with chronic migraine at a neurology clinic -
Exclusion
- none
- \-
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04871581
Start Date
October 1 2019
End Date
June 30 2020
Last Update
May 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boyd James
Solana Beach, California, United States, 92075